Company Overview - CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer [2][1] - The company aims to enhance the quality of life for urologic cancer patients through innovative immunotherapies [2] Upcoming Events - Arthur Kuan, Chairman & CEO, and Ambaw Bellete, President & COO, are scheduled to participate in fireside chat presentations at the Cantor Global Healthcare Conference on September 5, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025 [1][3] - Interested parties can access the live audio webcast from the Investor Relations section of the company's website, with a replay available for approximately 90 days after the live presentation [1]